Summary of Misdiagnosing Nasal Destruction as a Rare Disease:
Granulomatosis With Polyangiitis (GPA), a rare nasal disease causing inflammation of blood vessels, may be misdiagnosed as nasal damage from cocaine use due to the production of antibodies that mimic idiopathic GPA, according to a study in Rheumatology Advances in Practice. The study recommends testing for cocaine in patients with destructive nasal lesions or isolated sino-nasal disease before diagnosing GPA, as treatments may be ineffective and harmful for ongoing cocaine users. The researchers found that 86% of patients at vasculitis clinics had positive urine toxicology results for cocaine use. GPA affects approximately 3 out of every 100,000 people.
*****
New Research Shows that GPA May be Misdiagnosed Due to Cocaine Use
Granulomatosis With Polyangiitis (GPA), a rare nasal disease, can cause inflammation of the blood vessels and commonly presents with symptoms in the sinuses, throat, lungs, and kidneys. Cocaine can induce the production of antibodies that mimic idiopathic GPA, making diagnosis difficult. However, a new study in Rheumatology Advances in Practice reveals that GPA may be frequently misdiagnosed due to nasal damage from cocaine use. The researchers conducted a retrospective review of patients at vasculitis clinics, finding that 86% had positive urine toxicology results for cocaine use.
Testing for Cocaine May be Necessary for an Accurate GPA Diagnosis
As reported in the study, researchers believe that many patients with the sinus and limited nasal form of the disease may suffer from nasal damage due to cocaine usage. Cocaine is the second most commonly abused drug in the United Kingdom, with 2.6% of people between 16 and 59 years old using it. In the United States, 4.8 million people (1.7% of those over age 12) reported using cocaine in the past year. Cocaine can cause significant health problems, including cocaine-induced midline destructive lesions and other vascular problems.
Misdiagnosis can be Dangerous.
Together with occasional general symptoms such as arthralgia, fatigue, and skin rash, the similarity between GPA and damage due to cocaine makes diagnosis difficult for physicians. While GPA is rare, affecting approximately 3 out of every 100,000 people, the researchers here believe that the possibility for misdiagnosis is serious, as the common treatments for GPA may be ineffective and even dangerous for ongoing cocaine users.
A Retrospective Review of Patients
The researchers performed a retrospective review of patients who visited vasculitis clinics for treatment at Queen Elizabeth Hospital in Birmingham and the Royal Free Hospital in London. They identified 42 patients and found that current cocaine use was common; some 86% of samples provided were positive when routine urine toxicology was performed; 9 patients who denied ever using cocaine were identified as using cocaine based on urine toxicology analysis, while 11 who stated they were ex-users still tested positive. They noted that ten patients referred to vasculitis treatment centers had been previously given a GPA diagnosis and immunosuppressive drugs. Despite this treatment, they still had ongoing nasal problems.
Testing for Cocaine is Essential for GPA Diagnosis
Researchers have shown that testing for cocaine can prevent misdiagnosis of GPA and avoid further harm to patients. The researchers here believe doctors should test patients with destructive nasal lesions or isolated sino-nasal disease for cocaine before diagnosing them with GPA. Immunosuppressive drugs, they note, are often ineffective if cocaine use persists and would also increase the risk of significant adverse effects, including infection.
In conclusion, the new research shows that before diagnosing GPA, doctors should consider the possibility of cocaine usage, as this can cause misleading test results. The study highlights the importance of considering all possible causes before diagnosing, especially when treating patients with a history of drug abuse. If cocaine is found, specific treatment is necessary instead of treating the patient with ineffective GPA treatment.
Comments are closed